𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Chemotherapeutic agents enhance TRAIL-induced apoptosis in prostate cancer cells

✍ Scribed by A. Munshi; T. McDonnell; R. Meyn


Publisher
Springer
Year
2002
Tongue
English
Weight
154 KB
Volume
50
Category
Article
ISSN
0344-5704

No coin nor oath required. For personal study only.


📜 SIMILAR VOLUMES


Pretreatment of docetaxel enhances TRAIL
✍ Jinsang Yoo; Sung-Soo Park; Yong J. Lee 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 367 KB 👁 1 views

## Abstract Tumor necrosis factor‐related apoptosis‐inducing ligand (TRAIL) is a promising cancer therapeutic agent because of its tumor selectivity. TRAIL is known to induce apoptosis in cancer cells but spare most normal cells. In this study, we examined whether treatment of docetaxel (DTX) can e

Effect of hyperthermia and chemotherapeu
✍ Jinsang Yoo; Yong J. Lee 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 712 KB

## Abstract Tumor necrosis factor‐related apoptosis‐inducing ligand (TRAIL) is a promising cancer therapeutic agent because of its tumor selectivity. TRAIL is known to induce apoptosis in cancer cells but spare most normal cells. In the previous study [Yoo and Lee, 2007], we have reported that hype

Par-4 inducible apoptosis in prostate ca
✍ Sushma Gurumurthy; Vivek M. Rangnekar 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 93 KB

## Abstract Prostate cancer is associated with the inability of prostatic epithelial cells to undergo apoptosis rather than with increased cell proliferation. Prostate apoptosis response‐4 (Par‐4) is a unique pro‐apoptotic molecule that is capable of selectively inducing apoptosis in cancer cells w

Cyclooxygenase-2 inhibitor celecoxib aug
✍ Devendra S. Dandekar; Monica Lopez; Robert I. Carey; Bal L. Lokeshwar 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 French ⚖ 366 KB

## Abstract Many tumors constitutively express high levels of the inducible form of proinflammatory enzyme, cyclooxygenase‐2 (COX‐2). Increased COX‐2 expression is associated with tumor cell resistance to many cytotoxic chemotherapy drugs. Furthermore, increased resistance to cytotoxic antitumor dr